Authors: LANGREHR JM GLANEMANN M GUCKELBERGER O KLUPP J NEUMANN U MACHENS C LOHMANN R KNOOP M LOBECK H SCHLAG H KECK H SETTMACHER U BECHSTEIN WO NEUHAUS PJ

Citation: Jm. Langrehr et al., A RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY FOR IMMUNOSUPPRESSIVE INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION, Clinical transplantation, 12(4), 1998, pp. 303-312

Authors: LANGREHR JM SCHNELLER A GUCKELBERGER O LOHMANN R NEUMANN U JONAS S KLUPP J SETTMACHER U KNOOP M BECHSTEIN WO NEUHAUS PJ

Citation: Jm. Langrehr et al., COMPARISON OF QUADRUPLE INDUCTION INCLUDING ATG OR IL-2R ANTIBODY WITH FK506-BASED THERAPY AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 30(4), 1998, pp. 1439-1440

Authors: LANGREHR JM GLANEMANN M SCHNELLER A NEUMANN U GUCKELBERGER O LOHMANN R KLUPP J JONAS S KNOOP M LOBECK H SCHLAG H KECK H SETTMACHER U BECHSTEIN WO NEUHAUS PJ

Citation: Jm. Langrehr et al., A RANDOMIZED TRIAL COMPARING ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY ANDPLACEBO FOR IMMUNOSUPPRESSIVE THERAPY AFTER OLT, Transplantation proceedings, 30(4), 1998, pp. 1445-1446

Authors: NEUHAUS PJ

Citation: Pj. Neuhaus, OPTIMIZED FIRST-LINE FK506-BASED PROTOCOLS IN LIVER-TRANSPLANTATION -EXPERIENCE FROM THE UNIVERSITY-HOSPITAL-RUDOLF-VIRCHOW, BERLIN, Transplantation proceedings, 26(6), 1994, pp. 3264-3266